GHK-Cu Side Effects and Benefits: Research Data

What Is the Copper Peptide GHK-Cu?

GHK is a tripeptide, a chain of three amino acids: glycyl-L-histidyl-L-lysine. It was first isolated in 1973 from human plasma (serum), where it prolonged the survival of normal liver cells in culture.^[5] GHK binds copper ions with high affinity, and the resulting GHK-Cu complex was described in 1981 as a growth-modulating tripeptide from plasma.^[6] Its discoverer later described the GHK peptide, a human tri-peptide, as a regulator of tissue remodeling.^[7]

GHK-Cu is therefore a naturally occurring copper complex in the human body, and the synthetic form is the same copper peptide complex made in the laboratory. Its level falls with age: a 2018 review reports about 200 ng/mL in plasma at age 20 and about 80 ng/mL at age 60.^[8] The same name is used for cosmetic copper peptides in a GHK-Cu cream or GHK-Cu serum and for research peptide powders, which are different products with different evidence.

How the GHK-Cu Peptide Works: Collagen and Anti-Inflammatory Signals

In fibroblast cultures, GHK-Cu stimulated collagen synthesis, the first strong finding on collagen production.^[9] Later reviews by the peptide’s discoverer describe GHK as a natural modulator of multiple cellular pathways in skin regeneration and, in a review of its regenerative and protective actions using new gene data, report that it increases collagen and elastin production and changes the gene expression of many human genes involved in tissue repair, antioxidant defense and inflammation.^[10][8] Its authors work at a private skin-research company, so those reviews are best read alongside independent work.

Independent reviews agree on the preclinical direction: GHK-Cu increased extracellular matrix (type I collagen and glycosaminoglycans), modulated metalloproteinases, promoted new blood vessels and showed anti-inflammatory effects through lower TGF-β and IL-6.^[3] A 2026 review adds a chemistry caution: how much of a product is copper-bound and how much copper is free depends on the formulation, so different GHK-Cu products are not the same copper delivery system.^[11]

Potential GHK-Cu Benefits Studied So Far

Claims about skin rejuvenation and skin health are common online. The table separates what was reported from the type of evidence behind it. Statistically significant improvements in cells or animals do not show the same result in people.

Collagen Synthesis, Skin Elasticity and Skin Firmness

The 2018 review summarises 12-week studies of a GHK-Cu facial cream in 71 women and an eye cream in 41 women, reporting greater skin density and thickness, better skin firmness and elasticity, and fewer fine lines; in a thigh-skin comparison, collagen rose in 70% of women using GHK-Cu, against 50% with a vitamin C cream and 40% with retinoic acid.^[8] The 2026 systematic review counted two randomised trials and reported improved patient satisfaction after laser resurfacing and reduced wrinkle volume and wrinkle depth compared with controls, while noting a limited number of well-designed trials.^[3] An independent 2026 review called these historical cosmetic reports small or incompletely characterised.^[11] An early pilot study compared creams containing vitamin C, a copper-binding peptide and melatonin against tretinoin on the ultrastructure of normal skin.^[12] Whether topical products stimulate collagen production in people therefore rests on small studies.

Wound Healing and Tissue Repair

In rabbit wounds GHK improved wound contraction and granulation tissue; a collagen dressing containing GHK sped healing in healthy and diabetic rats; and GHK-Cu improved healing of ischemic open wounds in rats, with lower metalloproteinase levels.^[8] These are animal results on skin regeneration and tissue repair, not human wound data.

Hair Growth, Hair Follicles and Hair Loss

Reviews list larger hair follicle size and more hair growth among GHK-Cu’s reported actions in experimental models.^[8] In people, a six-month randomised, double-blind trial of a topical complex of 5-aminolevulinic acid and GHK in 45 patients with pattern hair loss found higher hair counts than placebo but no difference in hair thickness.^[2] A 2026 split-face eyebrow study in 18 participants also reported positive cosmetic hair results.^[11] Hair restoration claims for injectable GHK-Cu have no published human data behind them.

Topical vs Injectable GHK-Cu: Cream, Serum and Copper Delivery in Research

The research record splits by format, and this matters more than any single study. This section describes the formats studied; it is not a guide to using either.

• Topical GHK-Cu. Every human study in the 2026 reviews tested a GHK-Cu cream, serum or similar product applied to the skin surface.^[3][11] Formulation research focuses on getting the peptide through the skin barrier: microneedles and liposomes markedly improved transdermal delivery in experimental work.^[3]
• Injectable GHK-Cu. The animal wound studies in the 2018 review include GHK built into collagen dressings; none is a human injection study.^[8] The 2026 formulation review lists no human exposure data for systemic use.^[11] FDA cites limited human data and a risk of immune reactions for injectable routes.^[4]
• Regulatory split. For U.S. compounding, FDA lists GHK-Cu in Category 1 only “except for injectable routes of administration.”^[13]

In short, the human evidence for topical GHK-Cu is small but real, and for injectable GHK-Cu it is absent.

GHK-Cu Side Effects: Risks and Safety Data

What the published record shows on GHK-Cu side effects:

• Skin irritation. In a keratinocyte model, GHK-Cu was not cytotoxic and did not change skin-irritation biomarkers, while the copper compounds copper chloride and copper acetate raised several of them at the same concentrations. The authors judged GHK-Cu to have a low potential for skin irritation.^[1]
• Human trials. The six-month topical hair trial reported no adverse events in any group.^[2] In the laser study, GHK-Cu products did not reduce post-treatment redness compared with standard care.^[14]
• Injectable products. FDA states that compounded injectable GHK-Cu may pose a risk of immunogenicity from aggregation and peptide-related impurities, with limited human data.^[4] No human study of injected GHK-Cu has been published, so injection site reactions have not been measured.^[11]
• Copper and copper metabolism disorders. People with Wilson disease clear copper poorly and have a high risk of copper toxicity.^[15] The GHK-Cu studies reviewed here did not test people with copper metabolism disorders, and how much free copper a product releases depends on its formulation.^[11]
• Skin sensitivity and long-term use. The 2026 systematic review found too few well-designed trials to judge long-term effects or use on sensitive skin.^[3]

Is GHK-Cu FDA Approved?

GHK-Cu vs AHK-Cu and Other Copper Compounds

AHK-Cu (L-alanyl-L-histidyl-L-lysine-Cu) is a close copper tripeptide analogue that swaps glycine for alanine. In the main published study, AHK-Cu lengthened human hair follicles kept alive outside the body and increased the growth of dermal papilla cells, apparently by reducing their apoptosis; it has no published human trial.^[19] For the full hair-loss comparison, see AHK-Cu vs GHK-Cu vs PTD-DBM.

GHK-Cu is often grouped with BPC-157 and TB-500 as a repair peptide, and the three are sold together as the GLOW blend. They are unrelated molecules with separate evidence; see BPC-157 benefits and side effects, TB-500 benefits and side effects, GLOW peptide benefits and side effects and KPV vs BPC-157 vs GHK-Cu.

What the Research Does Not Yet Show

• Large independent trials. Most human data are small cosmetic studies, some reported only in reviews or conference proceedings.^[3][11]
• Any human data for injection. No published study gives human exposure or safety data for systemic GHK-Cu.^[11]
• A defined product. Copper binding and free copper vary by formulation and are rarely measured.^[11]
• Long-term safety. No study has followed users for years.^[3]

GHK-Cu for Laboratory Research

Remy Research supplies GHK-Cu for in-vitro research as the GHK-Cu 50mg research vial, the Genovare GHK-Cu 100mg AQ pen and the Genovare GHK-Cu 500mg AQ pen, and the related analogue as the Genovare AHK-Cu 100mg AQ pen. Each product page carries its batch testing details. For the full mechanism review, read the GHK-Cu research guide; for the cosmetic-versus-research distinction, see GHK-Cu vs copper peptide serum.